Amwell's total revenue was $62.2 million, with a gross margin of 43.5%. The company had a net loss of $50.9 million and an adjusted EBITDA of ($31.5) million. Total active providers were approximately 80,000 and total visits were approximately 1.4 million.
Revenue of $62.2 million in the third quarter
Gross margins of 43% of revenue compared to 33% last year
Total visits of 1.4 million
Total active providers of approximately 80,000 at the end of the third quarter versus 71,000 last quarter and 62,000 last year
For 2021, the Company is narrowing and adjusting their previous visits outlook as a direct result of the impact of the COVID-Delta variant and now expects: Revenue between $246 and $253 million and Adjusted EBITDA between ($143) and ($136) million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance